Raia Drogasil S.A.
RADLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.98 | 0.13 | -1.01 | 4.77 |
| FCF Yield | 1.99% | 0.70% | 0.72% | -0.61% |
| EV / EBITDA | 29.19 | 27.39 | 45.91 | 3,546.49 |
| Quality | ||||
| ROIC | 4.01% | 4.44% | 2.74% | 4.57% |
| Gross Margin | 24.92% | 29.55% | 28.69% | 29.62% |
| Cash Conversion Ratio | 2.19 | 1.24 | 2.60 | 1.65 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.70% | 8.92% | 9.37% | 10.17% |
| Free Cash Flow Growth | 257.66% | -31.21% | 223.17% | -149.92% |
| Safety | ||||
| Net Debt / EBITDA | 5.82 | 6.67 | 7.99 | 629.37 |
| Interest Coverage | 2.73 | 2.57 | 2.23 | 2.48 |
| Efficiency | ||||
| Inventory Turnover | 1.00 | 0.92 | 0.83 | 0.84 |
| Cash Conversion Cycle | 62.06 | 57.12 | 57.72 | 57.03 |